A recent study published in Nutrition & Diabetes conducted a meta-analysis of randomized clinical trials (RCTs) to evaluate the effects of taurine supplementation on metabolic syndrome (MetS). MetS is characterized by abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL cholesterol, increasing the risk of cardiovascular diseases and type 2 diabetes. Taurine has been identified as a potential treatment due to its role in mitochondrial function, osmoregulation, and antioxidant defense. The meta-analysis included 25 trials with 1,024 participants and found that taurine significantly reduced systolic blood pressure (−4 mmHg), diastolic blood pressure (−1.5 mmHg), fasting blood glucose (−5.9 mg/dL), and triglycerides (−18.3 mg/dL), though it had no significant effect on HDL levels. The findings suggest taurine may improve MetS outcomes by enhancing glycemic control and cardiovascular health, warranting further studies on optimal dosage and duration of taurine therapy for MetS management.
Home » Taurine Supplementation: A Promising Strategy for Managing Metabolic Syndrome
Taurine Supplementation: A Promising Strategy for Managing Metabolic Syndrome
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Elevating Breast Milk Microbiota with Prebiotic Support
February 15, 2025
Dietary Fiber PHGG Boosts Skin Hydration and Elasticity
February 7, 2025
Brussels Chicory for Enhanced Exercise Performance & Recovery
February 7, 2025
Salidroside and exercise performance in healthy active young adults
February 1, 2025
New Study Unveils Powerful Antioxidant Blend for Metabolic Health
February 1, 2025
Quinoa Leaves – Nature’s Nutraceutical Powerhouse
February 1, 2025